James R. Berenson, MD, Inc.

Dr. Berenson will be the featured Myeloma Cure Talk Panel member on this November 29th, 2012 @ 6:00 PM EST broadcast.  You can sign up for the broadcast at the following link: http://trialx.com/curetalk/panels/myeloma-cure-panel-with-dr-james-berenson-on-29-november-2012-6pm-est/ The discussion will cover Dr. Berenson’s multiple myeloma treatment philosophy and preferred treatment protocols.  He has been known for protocols that do not include [...]

UpdatesinTreatmentMM

The Institute for Myeloma & Bone Cancer Research (IMBCR) is pleased to announce the dedication of a newly designed artwork for IMBCR. Artist, Ted Kirby, named the artwork “Determination”, in honor of all those who are determined to cure Multiple Myeloma. Please join us for the dedication and to meet the artist, followed by a [...]

Oncotherapeutics, an oncology specific Contract Research Organization (CRO) specializing in the oversight and management of clinical trails for cnacer, will present final results from a multicenter clinical trial at the American Society of Hematology Annual Meeting in San Diego, CA on December 10-13, 2011.

The results of this landmark study should be welcomed news to cancer patients across the world suffering from the debilitating effects of painful vertebral compression fractures,” said Dr. James Berenson, the study’s first author and Medical and Scientific Director of the Institute for Myeloma and Bone Cancer Research in Los Angeles, CA. “It is documented [...]